Team:Virginia/Policy Proposal
This proposal was developed to encourage discussion regarding the state of synthetic biology regulations in the United States. More specifically, this proposal discusses the regulation of biological containment devices that are exposed to ecological settings. This issue is under-discussed and relatively unknown. Our team surveyed current iGEM teams, and found that even in this group, who is very familiar with synthetic biology, over one third of the respondents did not know what biological containment was.
Revisions to this document were informed by discussions with experts in the field. These experts include Dr. Jessica Tucker from the NIH, Deputy Commissioner Charles Green from Virginia’s Department of Agriculture and Consumer Services, and Branch Chief Alan Pearson from APHIS. Please see our Wiki page for more details on these conversations.
Introduction
This proposal describes rules and regulations regarding the testing, application, monitoring, and termination of biological containment devices. As new applications emerge, it will become essential to have regulation regarding biological containment devices in place to facilitate the smooth and safe introduction of novel technologies. For the purpose of these guidelines, a biological containment device refers to a biological system that utilizes cellular frameworks to establish control over an organism and where it can survive in an environmental setting. Biological containment devices will henceforth be referred to as devices.
No current regulation exists for devices in synthetic biology systems in ecological settings. While devices are not yet regulated, synthetically modified organisms are incompletely regulated, largely by the US Environmental Protection Agency (EPA), the US Department of Agriculture’s Animal and Plant Health Inspection Service (USDA/APHIS) and the US Food and Drug Administration (FDA). Among these agencies, different authorities regulate the development and the deployment of synthetically modified organisms, which presents a challenge in selecting one agency to regulate biological containment devices.1 We suggest to expand the authority of one of these agencies to encompass the regulation of devices.
The NIH, in its 2016 Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, hereinafter referred to as the NIH Guidelines, describes the guidelines for laboratory research involving synthetic genetic material.2 In contrast, there are three primary regulatory agencies for synthetic biology products: the EPA, USDA/APHIS and the FDA. A 2014 report on Synthetic Biology and the US Biotechnology Regulatory System by the J. Craig Venter Institute cites that these agencies have an adequate level of authority to address most, but not all, environmental, health and safety concerns with regard to synthetic biology.3 Because APHIS’ authority extends over engineered plants and the FDA’s authority extends over foods and drugs, the EPA is the most appropriate of these three agencies to make regulatory decisions based on risks posed by genetically modified microbes to health and safety of humans, animals and ecosystems. This proposal goes beyond the current scope of the EPA, but if adopted, could enhance the current regulatory model.
In this document, all references to the agency adopting these recommendations are marked in italics.
Developer SubmissionA developer must include the following items with every device submission:
Submission of devices is allowed at the beginning of each calendar year. After a device is submitted to the agency, it will undergo a series of confirmatory tests to determine its potential success and application.
